T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortinet
FTNT
|
+$2.03B |
| 2 |
Rockwell Automation
ROK
|
+$1.44B |
| 3 |
Autodesk
ADSK
|
+$1.15B |
| 4 |
Citigroup
C
|
+$975M |
| 5 |
ConocoPhillips
COP
|
+$967M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.59B |
| 2 |
GE Aerospace
GE
|
+$1.78B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.38B |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.08B |
| 5 |
Philip Morris
PM
|
+$1.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.21% |
| 2 | Healthcare | 15.42% |
| 3 | Financials | 10.99% |
| 4 | Consumer Discretionary | 10.39% |
| 5 | Communication Services | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2626
First US Bancshares
FUSB
$90.7M
| $194K | ﹤0.01% |
20,950
| – | – |
|
2627
Inogen
INGN
$154M
| $193K | ﹤0.01% |
23,868
+1,188
| +5% | +$8.41K |
|
|
IAS
2628
DELISTED
Integral Ad Science
IAS
| $192K | ﹤0.01% |
19,215
+6,878
| +56% | +$91.8K |
|
2629
DocGo
DCGO
$64.5M
| $191K | ﹤0.01% |
47,216
+11,174
| +31% | +$42.1K |
|
2630
RPC Inc
RES
$1.39B
| $189K | ﹤0.01% |
24,393
+3,650
| +18% | +$26.3K |
|
2631
Standard BioTools
LAB
$294M
| $187K | ﹤0.01% |
68,869
+42,069
| +157% | +$102K |
|
|
SGMO
2632
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $187K | ﹤0.01% |
278,704
+10,373
| +4% | +$7.52K |
|
2633
Aveanna Healthcare
AVAH
$2.46B
| $185K | ﹤0.01% |
74,061
+503
| +0.7% | +$1.21K |
|
|
STKL
2634
DELISTED
SunOpta
STKL
| $185K | ﹤0.01% |
26,913
+3,171
| +13% | +$19.6K |
|
2635
Hyliion Holdings
HYLN
$734M
| $184K | ﹤0.01% |
104,086
+8,580
| +9% | +$11.3K |
|
2636
Outset Medical
OM
$79.9M
| $184K | ﹤0.01% |
5,509
+2,366
| +75% | +$120K |
|
2637
Portillo's
PTLO
$365M
| $184K | ﹤0.01% |
12,963
+1,917
| +17% | +$26.6K |
|
2638
Accuray
ARAY
$32.9M
| $181K | ﹤0.01% |
73,146
+6,583
| +10% | +$17.6K |
|
2639
Mercer International
MERC
$33.8M
| $181K | ﹤0.01% |
18,123
| – | – |
|
2640
Montauk Renewables
MNTK
$268M
| $181K | ﹤0.01% |
43,329
+10,850
| +33% | +$68.1K |
|
2641
Asure Software
ASUR
$251M
| $180K | ﹤0.01% |
23,018
| – | – |
|
2642
FTAI Infrastructure
FIP
$551M
| $179K | ﹤0.01% |
28,483
+5,244
| +23% | +$24.3K |
|
|
CFB
2643
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $179K | ﹤0.01% |
12,920
+1,985
| +18% | +$26.6K |
|
|
LL
2644
DELISTED
LL Flooring Holdings, Inc.
LL
| $179K | ﹤0.01% |
97,400
| – | – |
|
2645
eHealth
EHTH
$38.8M
| $177K | ﹤0.01% |
29,294
+817
| +3% | +$5.42K |
|
2646
McEwen Inc
MUX
$1.14B
| $177K | ﹤0.01% |
17,900
| – | – |
|
|
TPC
2647
Tutor Perini Cor
TPC
$4.98B
| $177K | ﹤0.01% |
+12,235
| New | +$125K |
|
2648
Atomera
ATOM
$212M
| $176K | ﹤0.01% |
28,533
+1,214
| +4% | +$8.32K |
|
2649
Quad
QUAD
$506M
| $176K | ﹤0.01% |
33,027
| – | – |
|
|
BRY
2650
DELISTED
Berry Corp
BRY
| $175K | ﹤0.01% |
21,664
+2,999
| +16% | +$21K |
|
Similar funds
T. Rowe Price Associates's Q1 2024 Portfolio in Review
As of Q1 2024, T. Rowe Price Associates held 3,021 positions worth $816B, up 9.6% from $744B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q1 2024 filing shows 108 new, 1,941 increased, 738 reduced and 64 closed positions. Its largest new stake was GE Vernova: 2,687,194 shares worth $367M. The largest sale was NVIDIA, an estimated $2.59B.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q1 2024 buy was GE Vernova: 2,687,194 shares worth $367M.
- T. Rowe Price Associates added most to Fortinet in Q1 2024, an estimated $2.03B increase.
- T. Rowe Price Associates's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $2.59B.
- T. Rowe Price Associates fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $621M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $816B portfolio in Q1 2024.
- T. Rowe Price Associates opened 108 new positions and closed 64 in Q1 2024.
- T. Rowe Price Associates's portfolio value rose 9.6% quarter-over-quarter to $816B.
Based on T. Rowe Price Associates's 13F filing for Q1 2024, filed 15 May 2024.